dalteparin is a low molecular weight heparin (LMWH). It is an anti-coagulant that helps prevent blood clots from forming.
The mechanism of action of dalteparin is similar to that of other LMWHs. It works by binding to and inhibiting the activity of clotting factors in the blood, including thrombin and Factor Xa. This helps prevent blood clots’ formation and reduces the risk of thrombosis.
The spectrum of dalteparin includes a range of indications for which it can be used. It is commonly used to prevent and treat thrombosis, including deep vein thrombosis (DVT) and pulmonary embolism (PE). It may also be used to prevent clotting during surgery in patients with certain types of heart disease and unstable angina or non-Q-wave myocardial infarction (MI). dalteparin may also treat disseminated intravascular coagulation (DIC) in some instances.